Literature DB >> 10933690

Involvement of the zinc-binding capacity of Sendai virus V protein in viral pathogenesis.

C Huang1, K Kiyotani, Y Fujii, N Fukuhara, A Kato, Y Nagai, T Yoshida, T Sakaguchi.   

Abstract

The V protein of Sendai virus (SeV) is nonessential to virus replication in cell culture but indispensable to viral pathogenicity in mice. The highly conserved cysteine-rich zinc finger-like domain in its carboxyl terminus is believed to be responsible for this viral pathogenicity. In the present study, we showed that the cysteine-rich domain of the SeV V protein could actually bind zinc by using glutathione-S-transferase fusion proteins. When the seven conserved cysteine residues at positions 337, 341, 353, 355, 358, 362, and 365 were replaced individually, the zinc-binding capacities of the mutant proteins were greatly impaired, ranging from 22 to 68% of that of the wild type. We then recovered two mutant SeVs from cDNA, which have V-C(341)S and V-C(365)R mutations and represent maximal and minimal zinc-binding capacities among the corresponding mutant fusion proteins, respectively. The mutant viruses showed viral protein synthesis and growth patterns similar to those of wild-type SeV in cultured cells. However, the mutant viruses were strongly attenuated in mice in a way similar to that of SeV V(DeltaC), which has a truncated V protein lacking the cysteine-rich domain, by exhibiting earlier viral clearance from the mouse lung and less virulence to mice. We therefore conclude that the zinc-binding capacity of the V protein is involved in viral pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10933690      PMCID: PMC112313          DOI: 10.1128/jvi.74.17.7834-7841.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  29 in total

1.  Potential metal-binding domains in nucleic acid binding proteins.

Authors:  J M Berg
Journal:  Science       Date:  1986-04-25       Impact factor: 47.728

2.  The paramyxovirus, Sendai virus, V protein encodes a luxury function required for viral pathogenesis.

Authors:  A Kato; K Kiyotani; Y Sakai; T Yoshida; Y Nagai
Journal:  EMBO J       Date:  1997-02-03       Impact factor: 11.598

3.  Normal cellular replication of Sendai virus without the trans-frame, nonstructural V protein.

Authors:  C Delenda; S Hausmann; D Garcin; D Kolakofsky
Journal:  Virology       Date:  1997-02-03       Impact factor: 3.616

4.  Initiation of Sendai virus multiplication from transfected cDNA or RNA with negative or positive sense.

Authors:  A Kato; Y Sakai; T Shioda; T Kondo; M Nakanishi; Y Nagai
Journal:  Genes Cells       Date:  1996-06       Impact factor: 1.891

5.  Double-layered membrane vesicles released from mammalian cells infected with Sendai virus expressing the matrix protein of vesicular stomatitis virus.

Authors:  T Sakaguchi; T Uchiyama; Y Fujii; K Kiyotani; A Kato; Y Nagai; A Kawai; T Yoshida
Journal:  Virology       Date:  1999-10-10       Impact factor: 3.616

6.  Tat protein from human immunodeficiency virus forms a metal-linked dimer.

Authors:  A D Frankel; D S Bredt; C O Pabo
Journal:  Science       Date:  1988-04-01       Impact factor: 47.728

7.  An N-terminal domain of the Sendai paramyxovirus P protein acts as a chaperone for the NP protein during the nascent chain assembly step of genome replication.

Authors:  J Curran; J B Marq; D Kolakofsky
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

8.  The ion channel activity of the influenza virus M2 protein affects transport through the Golgi apparatus.

Authors:  T Sakaguchi; G P Leser; R A Lamb
Journal:  J Cell Biol       Date:  1996-05       Impact factor: 10.539

9.  The Newcastle disease virus V protein binds zinc.

Authors:  M Steward; A C Samson; W Errington; P T Emmerson
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

10.  Two mRNAs that differ by two nontemplated nucleotides encode the amino coterminal proteins P and V of the paramyxovirus SV5.

Authors:  S M Thomas; R A Lamb; R G Paterson
Journal:  Cell       Date:  1988-09-09       Impact factor: 41.582

View more
  21 in total

1.  Comparison of predicted amino acid sequences of measles virus strains in the Edmonston vaccine lineage.

Authors:  C L Parks; R A Lerch; P Walpita; H P Wang; M S Sidhu; S A Udem
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

2.  Inhibition of interferon regulatory factor 3 activation by paramyxovirus V protein.

Authors:  Takashi Irie; Katsuhiro Kiyotani; Tomoki Igarashi; Asuka Yoshida; Takemasa Sakaguchi
Journal:  J Virol       Date:  2012-04-24       Impact factor: 5.103

Review 3.  Paramyxovirus evasion of innate immunity: Diverse strategies for common targets.

Authors:  Michelle D Audsley; Gregory W Moseley
Journal:  World J Virol       Date:  2013-05-12

4.  Mutations in influenza virus M1 CCHH, the putative zinc finger motif, cause attenuation in mice and protect mice against lethal influenza virus infection.

Authors:  Eric Ka-Wai Hui; Donald F Smee; Min-Hui Wong; Debi P Nayak
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

5.  Importance of the anti-interferon capacity of Sendai virus C protein for pathogenicity in mice.

Authors:  Atsushi Kato; Katsuhiro Kiyotani; Toru Kubota; Tetsuya Yoshida; Masato Tashiro; Yoshiyuki Nagai
Journal:  J Virol       Date:  2007-01-10       Impact factor: 5.103

6.  Zinc binding activity of human metapneumovirus M2-1 protein is indispensable for viral replication and pathogenesis in vivo.

Authors:  Hui Cai; Yu Zhang; Yuanmei Ma; Jing Sun; Xueya Liang; Jianrong Li
Journal:  J Virol       Date:  2015-04-08       Impact factor: 5.103

7.  Identification of paramyxovirus V protein residues essential for STAT protein degradation and promotion of virus replication.

Authors:  Machiko Nishio; Masato Tsurudome; Morihiro Ito; Dominique Garcin; Daniel Kolakofsky; Yasuhiko Ito
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

8.  Alteration of Sendai virus morphogenesis and nucleocapsid incorporation due to mutation of cysteine residues of the matrix protein.

Authors:  Takemasa Sakaguchi; Tsuneo Uchiyama; Cheng Huang; Noriko Fukuhara; Katsuhiro Kiyotani; Yoshiyuki Nagai; Tetsuya Yoshida
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

9.  Newcastle disease virus V protein is associated with viral pathogenesis and functions as an alpha interferon antagonist.

Authors:  Zhuhui Huang; Sateesh Krishnamurthy; Aruna Panda; Siba K Samal
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

10.  The amino-terminal half of Sendai virus C protein is not responsible for either counteracting the antiviral action of interferons or down-regulating viral RNA synthesis.

Authors:  Atsushi Kato; Yukano Ohnishi; Michiko Hishiyama; Masayoshi Kohase; Sakura Saito; Masato Tashiro; Yoshiyuki Nagai
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.